ALD403

· Alder Biopharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for ALD403, covering 2013-04-26 to 2020-05-14. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter Assessment of ALD403 in Frequent Episodic Migraine [Phase 3]